Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers compared ALKS 9072 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared Intramuscular Levosulpiride and Intramuscular Haloperidol to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingResearchers compared Quetiapine and risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including ShanghaiThis study evaluated the safety and effectiveness of Clozapine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including ChibaResearchers are comparing PF-04958242 and placebo to find out how the approaches affect memory, attention and other thinking skills in people with schizophrenia.
This study ended early.
Multiple locations, including Garden Grove
Electronic Schizophrenia Treatment Adherence Registry(e-STAR): An Observational, International Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres
This study has finished and is no longer accepting participants.
Location not clearly listedA RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, SPONSOR OPEN, PHASE 1B STUDY TO EXAMINE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF PF-06412562 IN PSYCHIATRICALLY STABLE SUBJECTS WITH SCHIZOPHRENIA
This study has finished and is no longer accepting participants.
Multiple locations, including ArcadiaThis study evaluated the safety of PF-02545920 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In GlendaleThis study evaluated the safety of PF-04958242 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In Long BeachA Phase II Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Four Orally Administrated Doses of BI 409306 During a 12-week Treatment Period in Patients With Schizophrenia on Stable Antipsychotic Treatment
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA First in Human Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of KYN-5356 in Adult, Healthy Subjects
This study has finished and is no longer accepting participants.
In GlendaleRECONNECT-S ALPHA: A Non-interventional Study to Observe Real-life Allocation of Antipsychotics in the Acute Inpatient Management of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including ChitaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.